These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10480712)

  • 1. A likelihood-based method of identifying contaminated lots of blood product.
    Reilly M; Lawlor E
    Int J Epidemiol; 1999 Aug; 28(4):787-92. PubMed ID: 10480712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmission rates of hepatitis C virus by different batches of a contaminated anti-D immunoglobulin preparation.
    Lawlor E; Power J; Garson J; Yap P; Davidson F; Columb G; Smith D; Pomeroy L; O'Riordan J; Simmonds P; Tedder R
    Vox Sang; 1999; 76(3):138-43. PubMed ID: 10341327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A second outbreak of hepatitis C virus infection from anti-D immunoglobulin in Ireland.
    Smith DB; Lawlor E; Power J; O'Riordan J; McAllister J; Lycett C; Davidson F; Pathirana S; Garson JA; Tedder RS; Yap PL; Simmonds P
    Vox Sang; 1999; 76(3):175-80. PubMed ID: 10341334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral transmission by blood products: a perspective of events covered by the recent tribunal of enquiry into the Irish Blood Transfusion Board.
    Yap PL
    Ir Med J; 1997; 90(3):84, 86, 88. PubMed ID: 9183082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adverse effects and patient information].
    Cortey A; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S112-1S118. PubMed ID: 16495836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin.
    Lawlor E; Columb G
    N Engl J Med; 1999 Sep; 341(10):762; author reply 763. PubMed ID: 10475797
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis C virus and intravenous anti-D immunoglobulin.
    Commun Dis Rep CDR Wkly; 1995 Jun; 5(24):111, 114. PubMed ID: 7542122
    [No Abstract]   [Full Text] [Related]  

  • 8. Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios.
    El Ekiaby M; Moftah F; Goubran H; van Drimmelen H; LaPerche S; Kleinman S; Busch M; Lelie N
    Transfusion; 2015 Jun; 55(6):1186-94. PubMed ID: 25766141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low rate of HCV transmission from women infected with contaminated anti-D immunoglobulin to their family contacts.
    Sachithanandan S; Fielding JF
    Ital J Gastroenterol Hepatol; 1997 Feb; 29(1):47-50. PubMed ID: 9265578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy and pregnancy outcome in hepatitis C type 1b.
    Jabeen T; Cannon B; Hogan J; Crowley M; Devereux C; Fanning L; Kenny-Walsh E; Shanahan F; Whelton MJ
    QJM; 2000 Sep; 93(9):597-601. PubMed ID: 10984554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can serological methods help distinguish between prophylactic and alloimmune anti-D?
    Irving C; Crennan M; Vanniasinkam T
    Transfus Med; 2017 Oct; 27 Suppl 5():362-368. PubMed ID: 28508562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis C infection from anti-D immunoglobulin.
    Power JP; Davidson F; O'Riordan J; Simmonds P; Yap PL; Lawlor E
    Lancet; 1995 Aug; 346(8971):372-3. PubMed ID: 7677904
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin.
    Jonas MM; Baron MJ; Bresee JS; Schneider LC
    Pediatrics; 1996 Aug; 98(2 Pt 1):211-5. PubMed ID: 8692620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of fetal RHD type in plasma of RhD negative pregnant women.
    Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA
    Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A competitive enzyme-linked immunoassay using erythrocytes fixed to microtitre plates for anti-D quantitation in immunoglobulin products.
    Thorpe SJ; Turner CE; Heath AC; Sands D
    Vox Sang; 2000; 79(2):100-7. PubMed ID: 11054048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New recommendations for the completion of rhesus-immunization prophylaxis with anti-D].
    Maas DH; Schneider J
    Immun Infekt; 1982 Nov; 10(6):244-9. PubMed ID: 6307863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemolytic disease of the fetus and newborn due to multiple maternal antibodies.
    Markham KB; Rossi KQ; Nagaraja HN; O'Shaughnessy RW
    Am J Obstet Gynecol; 2015 Jul; 213(1):68.e1-68.e5. PubMed ID: 25644438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a general hepatitis C lookback program for persons who received blood transfusions in a neonatal intensive care unit between January 1975 and July 1992.
    Cagle HH; Jacob J; Homan CE; Williams JL; Christensen CJ; McMahon BJ
    Arch Pediatr Adolesc Med; 2007 Feb; 161(2):125-30. PubMed ID: 17283296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prenatal immunoglobulin prevention in Rh(D)-negative nonsensitized pregnant women].
    Katsulov A
    Akush Ginekol (Sofiia); 1997; 36(2):1-2. PubMed ID: 9471891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.